Manufacturing Round-Up: Sterling Completes Expansion As Xellia Teams With Civica Rx

Sterling Pharma Solutions completes an expansion of its UK pilot plant facility, Aphena invests, Dr Reddy’s and Asymchem get nods from the FDA, Ampersand Capital Partners acquires Germany’s Vibalogics, and Xellia strikes a deal with Civica Rx.

Work station
• Source: Shutterstock

Sterling Pharma Solutions has announced that the expansion of its pilot plant facility in the UK is now operational, following a £6m ($8m) investment last year. The new facility – which includes three new reactor trains at scales of 225l, 500l and 1,360l – “increases the existing pilot plant’s capacity by 33%, enhancing the contract development and manufacturing organization’s (CDMO’s) scale-up capabilities and adding greater flexibility to cater for small to mid-scale clinical supply and commercial batch production,” Sterling commented.

Kevin Cook, Sterling’s CEO, said the ability to cater for smaller volumes would be “essential as we move forward,” due...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Manufacturing

More from Business